Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Cancer immune evasion, immunoediting and intratumour heterogeneity
2025 Standout
Works of Xiaochen Hu being referenced
MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Xiaochen Hu | 165 | 214 | 92 | 26 | 526 | |
| Liangliang Cai | 253 | 128 | 103 | 41 | 548 | |
| Zhao Wu | 331 | 127 | 47 | 38 | 594 | |
| Zinan Li | 303 | 116 | 76 | 29 | 607 | |
| Xiao Han | 224 | 206 | 64 | 17 | 615 | |
| Jing Peng | 203 | 185 | 60 | 24 | 495 | |
| Xiumei Zheng | 224 | 169 | 67 | 23 | 507 | |
| Yuhong Sun | 220 | 113 | 75 | 24 | 537 | |
| Dajian Zhu | 228 | 189 | 101 | 25 | 503 | |
| Ebru Alp | 272 | 91 | 40 | 35 | 615 | |
| Ming-Tsung Lai | 306 | 115 | 99 | 17 | 599 |
All Works
Login with ORCID to disown or claim papers
Loading papers...